Page last updated: 2024-11-02

p-fluorophenylalanine and Parkinson Disease

p-fluorophenylalanine has been researched along with Parkinson Disease in 1 studies

p-Fluorophenylalanine: 3-(p-Fluorophenyl)-alanine.
4-fluorophenylalanine : A phenylalanine derivative in which the hydrogen at position 4 on the benzene ring is replaced by a fluoro group.

Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dhawan, V1
Ma, Y1
Pillai, V1
Spetsieris, P1
Chaly, T1
Belakhlef, A1
Margouleff, C1
Eidelberg, D1

Other Studies

1 other study available for p-fluorophenylalanine and Parkinson Disease

ArticleYear
Comparative analysis of striatal FDOPA uptake in Parkinson's disease: ratio method versus graphical approach.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2002, Volume: 43, Issue:10

    Topics: Case-Control Studies; Corpus Striatum; Female; Fluorine Radioisotopes; Humans; Male; Middle Aged; p-

2002